Which two receptor types are commonly targeted by medications?

• A. Nuclear receptors and intracellular enzymes
• B. G-protein-coupled receptors and ligand-gated ion channels
• C. Ionotropic receptors and metabotropic receptors
• D. Tyrosine kinase receptors and cytokine receptors

Answer: (B)

Medications most often affect receptors that sit on the cell surface and can quickly translate binding into cellular signals. Two main types are especially common targets because they deliver fast, controllable effects and are readily accessible to drugs.

G-protein-coupled receptors are a vast and versatile family. When a drug binds, it sets off intracellular G proteins that change second messengers and downstream signaling, producing a wide range of physiological responses. This makes them highly druggable: a diverse set of small molecules and biologics can modulate them, and their surface location allows easy drug access. Classic examples include beta blockers and many allergy or psychiatric meds that adjust signaling through these receptors, as well as opioids that act on mu-opioid GPCRs.

Ligand-gated ion channels respond to a neurotransmitter by opening an ion pore, causing rapid changes in the cell’s membrane potential. Drugs can enhance or block this immediate signaling, giving fast therapeutic effects used in anesthesia, epilepsy, pain management, and more. Benzodiazepines, for instance, modulate the GABA-A receptor, a fast-acting ligand-gated chloride channel, producing quick calming and sedative effects. Other drugs target nicotinic acetylcholine receptors or glutamate receptors, illustrating how these channels provide swift control of neuronal signaling.

Other receptor types exist, but are not as commonly targeted in everyday meds for broad, rapid control of signaling. Nuclear receptors and intracellular enzymes often involve slower genomic or metabolic effects, while tyrosine kinase and cytokine receptors are important targets as well, yet the most consistently exploited drug targets for broad therapeutic modulation are surface GPCRs and ligand-gated ion channels.